Loading...
Thumbnail Image
Item

Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: The EURODIAB Prospective Complications Study

Soulimane,S.
Balkau,B.
Vogtschmidt,Y.D.
Toeller,M.
Fuller,J.H.
Soedamah-Muthu,S.S.
Abstract
Aims The aim of this prospective study was to examine CVD risk reduction in type 1 diabetes (1) for people with favourable cardiovascular health metrics and (2) by clustering of these metrics. Methods Data from 2313 participants from the EURODIAB Prospective Complications Study were analysed. All had type 1 diabetes (51% men, mean ± SD age 32 ± 9 years). Seven cardiovascular health metrics were studied-smoking, BMI, physical activity, a diet score, total cholesterol/HDL-cholesterol ratio, combined systolic and diastolic BP and HbA1c-divided into favourable/less favourable categories. Cox proportional hazards models were used to calculate HRs (95% CIs) of incident CVD for each metric. Clusters were made by scoring each individual by the number of favourable metrics. Results A total of 163 people developed incident CVD during a mean ± SD follow-up of 7.2 ± 1.3 years. Participants with more favourable HbA1c levels of <57 mmol/mol (<7.4%) had a 37% significantly lower CVD risk than those with a less favourable HbA1c (HR [95% CI] 0.63 [0.44, 0.91]), and participants with a more favourable BP (systolic BP <112 mmHg and diastolic BP <70 mmHg) had a 44% significantly lower CVD risk than participants in the less favourable BP group (HR [95% CI] 0.56 [0.34, 0.92]). There was a dose-response relation with a lower HR observed with greater clustering of more favourable metrics: people with four or more favourable metrics had an HR of 0.37 (95% CI 0.18, 0.76), adjusted for sex and age at diabetes diagnosis, compared with those with no favourable metrics. Conclusions/interpretation Low HbA1c and low BP were protective cardiovascular health metrics in our study of people with type 1 diabetes. Targeting all cardiovascular health metrics could be more effective in preventing CVD than targeting single metrics.
Description
The EURODIAB Prospective Complications Study was supported by grants from the Wellcome Trust, the European Community and Diabetes UK. Additional financial support was provided by Gesellschaft von Freunden und Förderern of Heinrich Heine University Düsseldorf, Germany, to the nutrition co-ordinating centre (MT).
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Keywords
ADULTS, ALL-CAUSE MORTALITY, ASSOCIATIONS, Cardiovascular health metrics, EUROPE, HEALTH, HEART-DISEASE, HbA(1c), OUTCOMES, PHYSICAL-ACTIVITY, Risk factors, SOCIOECONOMIC-STATUS, TRENDS, Type 1 diabetes, SDG 3 - Good Health and Well-being
Citation
Soulimane, S, Balkau, B, Vogtschmidt, Y D, Toeller, M, Fuller, J H & Soedamah-Muthu, S S 2022, 'Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes : The EURODIAB Prospective Complications Study', Diabetologia, vol. 65, no. 7, pp. 1169-1178. https://doi.org/10.1007/s00125-022-05698-2
License
info:eu-repo/semantics/openAccess
Embedded videos